RCM
MDCO

RA Capital Management’s Medicines Co MDCO Stock Holding History

RA Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-79,899
Closed -$3.91M – 30
2017
Q1 		$3.91M Hold
79,899
– – 0.48% 24
2016
Q4 		$2.71M Buy
+79,899
New +$2.83M 0.38% 25
2015
Q3 		– Sell
-705,925
Closed -$20.2M – 69
2015
Q2 		$20.2M Buy
+705,925
New +$19.7M 2.03% 17

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RA Capital Management's MDCO Position: Q2 2017 in Review

RA Capital Management sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 79,899 shares — an estimated $3.91M sold.

RA Capital Management first reported a position in MDCO in Q2 2015 and held it in 3 quarters. The position peaked at $20.2M in Q2 2015. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • RA Capital Management reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • RA Capital Management sold 79,899 Medicines Co shares in Q2 2017, an estimated $3.91M.
  • RA Capital Management first reported a position in Medicines Co in Q2 2015 and held it in 3 quarters.
  • RA Capital Management's Medicines Co position peaked at $20.2M in Q2 2015.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on RA Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.